News

Targeted and immunotherapies: Boosting bladder cancer research

Targeted and immunotherapies: Boosting bladder cancer research

Bladder cancer is a urological malignancy that remains a challenge to both clinicians and researchers. However, recent developments indicate that targeted and immunotherapies will increasingly take a front-line role in treating this deadly disease which is considered as the...

High hopes for advances in bladder cancer treatment

Cancer experts have high hopes for advances in bladder cancer treatment despite the widespread perception among medical professionals that studies on the deadly disease are fewer compared with other onco-urological malignancies such as prostate cancer. At the upcoming 7th...

6th EMUC: Issues and challenges in small renal masses

The various approaches in managing small renal masses ranging from the role of imaging, renal biopsy, active surveillance to focal treatments and radiotherapy were closely examined and discussed in the second day plenary session of the 6th European Multidisciplinary...

6th EMUC: Updates and prospects in bladder cancer

Developments and prospects in bladder cancer treatment were examined at the 6th European Multidisciplinary Meeting on Urological Cancers (EMUC) in Lisbon, Portugal with experts assessing the efficacy of new imaging tools and the options on how to further refine...

6th EMUC: Experts examine strategies in prostate cancer management

Optimising treatment and management strategies in prostate cancer took up the first plenary session of the 6th European Multidisciplinary Meeting on Urological Cancers (EMUC) in Lisbon, Portugal, with experts discussing prospects in imaging, radiotherapy and benefits of medical treatment....

6th EMUC: updates on locally advanced kidney cancer

Genomics will play a crucial role in the coming years in managing locally advanced kidney cancer, but the entry of new drugs also carry with it several challenges such as the issue of drug resistance and the role of...

Renewed interest in immunotherapy in treating kidney cancer

There is a renewed interest from medical researchers to further investigate the efficacy of immunotherapy for treating kidney cancer following the improved understanding of basic cancer immunology, according to cancer experts during the EAU-ICUD Medical Treatment of Urological Malignancies...
Genomics, drug sequencing: key areas in high-risk prostate cancer

Genomics, drug sequencing: key areas in high-risk prostate cancer

The role of genomics in identifying patients who will benefit from adjuvant treatments, targeted therapy and drug sequencing combinations is among the key areas that require closer attention from researchers investigating metastatic, high-risk prostate cancer. “Genomics is helping to...